Ficaprenol-11 is a compound that can be isolated from the leaves of Ficus elastica[1].

FICD Human Pre-designed siRNA Set A contains three designed siRNAs for FICD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fidexaban is a Factor Xa inhibitor and can be used in research of cardiovascular disease[1].

ALK2-IN-1 is a activin receptor-like kinase-2 (ALK2) inhibitor extracted from patent WO2017181117A1, Compound 876, has an IC50 of

ALK2-IN-1 is a activin receptor-like kinase-2 (ALK2) inhibitor extracted from patent WO2017181117A1, Compound 876, has an IC50 of

ALK2-IN-1 is a activin receptor-like kinase-2 (ALK2) inhibitor extracted from patent WO2017181117A1, Compound 876, has an IC50 of

FIG4 Human Pre-designed siRNA Set A contains three designed siRNAs for FIG4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FIGLA Human Pre-designed siRNA Set A contains three designed siRNAs for FIGLA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FIGN Human Pre-designed siRNA Set A contains three designed siRNAs for FIGN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FIGNL1 Human Pre-designed siRNA Set A contains three designed siRNAs for FIGNL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FILIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for FILIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FILIP1L Human Pre-designed siRNA Set A contains three designed siRNAs for FILIP1L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Finasteride carboxaldehyde (Compound M2) is the metabolite of 5α-reductase inhibitor Finasteride (HY-13635) in human bile and urine[1].

Fingolimod (hydrochloride) (Standard) is the analytical standard of Fingolimod (hydrochloride). This product is intended for research and analytical applications. Fingolimod hydrochloride (FTY720), an analog of sphingosine, is a potent sphingosine 1-phosphate (S1P) receptors modulator. Fingolimod hydrochloride is phosphorylated by sphingosine kinases, particularly by SK2, and then binds S1PR1, 3, 4, and 5. Fingolimod hydrochloride induces […]

FIP1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for FIP1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fipronil (Standard) is the analytical standard of Fipronil. This product is intended for research and analytical applications. Fipronil is a broad-spectrum insecticide effective against Lepidoptera species as well as thrips, locusts, ants, cockroaches, fleas and ticks. Fipronil selectively inhibits GABA receptor with IC50s of 30 nM and 1600 nM for cockroach and rat GABA receptors, […]

Firocoxib (Standard) is the analytical standard of Firocoxib. This product is intended for research and analytical applications. Firocoxib (ML 1785713) is a potent, selective and orally active COX-2 inhibitor with an IC50 of 0.13 μM. Firocoxib shows 58-fold more selective for COX-2 than COX-1 (IC50 of 7.5 μM). Firocoxib has anti-inflammatory effects[1].

FIS1 Human Pre-designed siRNA Set A contains three designed siRNAs for FIS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FITC-Lithocholic acid 3-sulfate (FITC-Sulfolithocholic acid) is a FITC-labeled Lithocholic acid 3-sulfate, which is a sulfated biliary metabolite. Lithocholic acid 3-sulfate selectively inhibits Th17 cell differentiation by targeting RORγt. Lithocholic acid 3-sulfate can be used for the research of pathogenesis of cholestatic liver diseases[1].

FITM1 Human Pre-designed siRNA Set A contains three designed siRNAs for FITM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FITM2 Human Pre-designed siRNA Set A contains three designed siRNAs for FITM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fitusiran sodium, an small interfering RNA, specifically targets antithrombin (AT) messenger RNA to lower production of AT in the liver. Fitusiran sodium increases thrombin generation and has the potential for the research of the hemophilia[1].

Fitusiran sodium, an small interfering RNA, specifically targets antithrombin (AT) messenger RNA to lower production of AT in the liver. Fitusiran sodium increases thrombin generation and has the potential for the research of the hemophilia[1].

Fitusiran sodium, an small interfering RNA, specifically targets antithrombin (AT) messenger RNA to lower production of AT in the liver. Fitusiran sodium increases thrombin generation and has the potential for the research of the hemophilia[1].

FIZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for FIZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FJX1 Human Pre-designed siRNA Set A contains three designed siRNAs for FJX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP10 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP11 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP14 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP15 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP1A Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP1B Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP3 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP4 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP5 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP51-Hsp90-IN-1 (Compound D10) is a selective inhibitor of the FKBP51-Hsp90 protein-protein interaction, with an IC50 value of 0.1 μM against FKBP51. FKBP51-Hsp90-IN-1 can be used in the research of stress-related diseases, Alzheimer’s disease, and metabolic disorders[1].

FKBP51-Hsp90-IN-2 (Compound E08) is a selective FKBP51–Hsp90 protein-protein interaction inhibitor with IC50 values of 0.4 µM and 5 µM for FKBP51 and FKBP52, respectively. FKBP51-Hsp90-IN-2 also effectively stimulates cellular energy metabolism and neurite growth. FKBP51-Hsp90-IN-2 can be used in research on neurodegenerative diseases and cancer[1].

FKBP6 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP7 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP8 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBP9 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKBPL Human Pre-designed siRNA Set A contains three designed siRNAs for FKBPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FKRP Human Pre-designed siRNA Set A contains three designed siRNAs for FKRP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.